Skip to search formSkip to main contentSkip to account menu

Copaxone

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system. We and others have shown that there is… 
Review
2015
Review
2015
2008
2008
Purpose: Drusen formation in age-related macular degeneration (AMD) shares some similarities with Alzheimer's disease (AD), which… 
Highly Cited
2003
Highly Cited
2003
Glatiramer acetate (GA; copolymer-1, Copaxone) suppresses the induction of experimental autoimmune encephalomyelitis and reduces… 
Highly Cited
2002
Highly Cited
2002
Glatiramer acetate (GA; Copaxone) is a random copolymer of glutamic acid, lysine, alanine, and tyrosine that is used… 
Highly Cited
2001
Highly Cited
2001
Copolymer-1 (Copaxone or COP) inhibits experimental allergic encephalomyelitis and has beneficial effects in multiple sclerosis… 
Highly Cited
2001
Highly Cited
2001
&NA; The purpose of this study was to evaluate psychological, biophysical, and sociodemographic variables as predictors of… 
Highly Cited
2001
Highly Cited
2000
Highly Cited
2000
We examined the effect of glatiramer acetate, a random copolymer of alanine, lysine, glutamic acid, and tyrosine, on antigen… 
Highly Cited
1998
Highly Cited
1998
When 251 relapsing-remitting patients with multiple sclerosis were randomized to receive daily subcutaneous injections of…